Cargando…
History and Future of Nucleic Acid Amplification Technology Blood Donor Testing
The introduction of blood donor screening by virus nucleic acid amplification technology (NAT) in the mid to late 1990s was driven by the so-called AIDS and hepatitis C virus (HCV) epidemic, with thousands of recipients of infected blood products and components. Plasma fractionators were the first t...
Autor principal: | Roth, Willi Kurt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514489/ https://www.ncbi.nlm.nih.gov/pubmed/31191192 http://dx.doi.org/10.1159/000496749 |
Ejemplares similares
-
Characteristic of HBV nucleic acid amplification testing yields from blood donors in China
por: Wu, Danxiao, et al.
Publicado: (2021) -
Current and Future Perspectives on Isothermal Nucleic Acid Amplification Technologies for Diagnosing Infections
por: Obande, Godwin Attah, et al.
Publicado: (2020) -
Isothermal Nucleic Acid Amplification Technologies for the Detection of Equine Viral Pathogens
por: Knox, Alexandra, et al.
Publicado: (2021) -
Microfluidic chip and isothermal amplification technologies for the detection of pathogenic nucleic acid
por: Gao, Dongli, et al.
Publicado: (2022) -
Isothermal nucleic acid amplification and its uses in modern diagnostic technologies
por: Srivastava, Pulkit, et al.
Publicado: (2023)